Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss) from operations	$ (2,989,904)	$ (1,821,013)
Mark-to-market adjustments		(186)
Net change due to non-cash issuances of stock	1,804,273	2,082,983
Cash in transit		9,500
Derivative liabilities		(613,309)
(Increase) decrease in assets and prepaid expenses
Total deferred financing costs		(185,965)
Total (increase) decrease in assets and prepaid expenses		(185,965)
Increase (decrease) in accounts payable and accrued expenses
Accounts payable	(170)	(4,350)
Sub-fund obligations		11,844
Accrued expenses	563,331	118,268
Advances from customers		(5,000)
Total increase (decrease) in accounts payable and accrued expenses	563,161	120,762
Net cash provided by (used in) operating activities	(622,470)	(407,228)
Cash flows from investing activities:
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Loans from Directors/Officers	(25,291)	(41,332)
Loans and Notes payable	(105,288)	378,590
Common Stock to be issued	737,062	16,000
Net cash provided by (used in) financing activities	606,483	353,258
Net decrease in cash and cash equivalents	(15,987)	(53,970)
Cash and cash equivalents, beginning of period	19,764	67,896
Cash and cash equivalents, end of period	$ 3,778	$ 13,926